CORRECTION: Agilon Health Raises FY2026 Sales Guidance from $5.680B-$5.805B to $5.775B-$5.860B vs $5.719B Est
Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.680 billion-$5.805 billion to $5.775 billion-$5.860 billion vs $5.719 billion estimate.
Agilon Health thinks it will make more money next year than it said before, and now expects higher sales than what experts predicted. When a company raises its money forecast, it usually means business is going better than expected, so that's something to notice.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.